GLP-1RA Use and Thyroid Cancer Risk
This secondary analysis of a target trial emulation of a comparative effectiveness study uses claims data to estimate the risk of incident thyroid cancer in adults with type 2 diabetes starting treatment with glucagon-like peptide-1 receptor agonists compared with other glucose-lowering medications.